| Overview |
| bs-5570R-PE-Cy5.5 |
| PI3KCA(Tyr317) Polyclonal Antibody, PE-Cy5.5 Conjugated |
| WB |
| Human, Mouse, Bovine |
| Rat |
| Specifications |
| PE-Cy5.5 |
| Rabbit |
| KLH conjugated synthetic phosphopeptide derived from human PI3KCA around the phosphorylation site of Tyr317 |
| Tyr317 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 5106 |
| Q16822 |
| Cytoplasm, Cell membrane |
| PEPCK; PEPCK2; PEPCK-M; Phosphoenolpyruvate carboxykinase [GTP], mitochondrial; PCK2 |
| Catalyzes the conversion of oxaloacetate (OAA) to phosphoenolpyruvate (PEP), the rate-limiting step in the metabolic pathway that produces glucose from lactate and other precursors derived from the citric acid cycle. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz